Statement of Deviation & Variation, 30-09-2026.

Compliance -57(5) Intimation after the end of quarter

Compliance -57(4)

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Transgene Biotek Ltd 2 CIN NO. L85195TG1990PLC011065 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4 Highest Credit Rating during the previous FY 0 4a Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) Not Applicable 5 Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework BSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: ANKITA JAIN Designation: COMPANY SECRETARY EmailId: j.ankita0025@gmail.com Name of the Chief Financial Officer: PRASAD CHOWDARY Designation: CFO EmailId: accounts@transgenebiotek.com Date: 03/10/2026 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Compliance Certificate 7(3) as on 30-09-2026.

Compliances Certificate under Reg. 74(5)

Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/10/2026 ,inter alia, to consider and approve To consider and approve the appointment of M/s. Eswara Rao & Co., Chartered Accountants, Firm Registration No. 000816S, as the Statutory Auditors of the Company to fill the casual vacancy caused by the resignation of M/s. Vasavi & Co., Chartered Accountants, subject to the recommendation of the Audit Committee and approval of the members of the Company at a general meeting, in accordance with the applicable provisions of the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015..